What Qorvo (QRVO)'s Stronger Earnings and $1.58 Billion Buyback Completion Means For Shareholders

Qorvo, Inc.

Qorvo, Inc.

QRVO

0.00

  • Qorvo’s latest quarterly report showed that, for the period ended March 28, 2026, sales eased to US$808.28 million and net income to US$29.73 million, while full-year sales slipped slightly to US$3.68 billion but net income increased to US$338.99 million, alongside completion of a US$1.58 billion share repurchase program that retired 18.33% of its stock.
  • At the same time, Qorvo awarded equity to senior executives with shares withheld only for taxes, signaling continued alignment of management incentives with shareholders during a period when sector-wide macro pressures, rather than company-specific issues, have been the main influence on sentiment.
  • We’ll now examine how Qorvo’s stronger full-year earnings and completed US$1.58 billion buyback interact with its existing investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 42 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Qorvo Investment Narrative Recap

To own Qorvo, you need to believe its RF expertise will keep it relevant across 5G, Wi Fi and diversified IoT, even as handset demand and customer concentration remain key swing factors. The latest quarter showed softer Q4 sales but a much stronger full year profit, and the share price move after the hot CPI print looks more linked to macro worries than to a fundamental change in Qorvo’s near term earnings catalyst or its biggest risk around revenue concentration.

The completion of the US$1.58 billion buyback, retiring 18.33% of shares, is especially relevant here because it directly affects per share earnings power and how investors weigh Qorvo’s slower top line against improving profitability. Combined with ongoing equity awards to senior executives that increased, rather than reduced, their net holdings, this capital allocation stance sits alongside the existing catalysts in infrastructure, defense and IoT, and may influence how investors judge any future swings in handset driven revenue.

Yet, against these positives, investors should still be aware of the risk that heightened trade tensions and China focused tariffs could...

Qorvo's narrative projects $4.0 billion revenue and $552.0 million earnings by 2029. This requires 1.9% yearly revenue growth and about a $211 million earnings increase from $340.6 million today.

Uncover how Qorvo's forecasts yield a $88.87 fair value, a 4% downside to its current price.

Exploring Other Perspectives

QRVO 1-Year Stock Price Chart
QRVO 1-Year Stock Price Chart

Some of the lowest ranked analysts paint a far more cautious picture, assuming roughly flat revenues near US$3.8 billion and earnings around US$572 million by 2029, and highlighting risks from in sourcing by major customers and geopolitical limits on China growth that the latest results and buyback activity may or may not fully address once their models are updated.

Explore 3 other fair value estimates on Qorvo - why the stock might be worth just $88.87!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Qorvo research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Qorvo research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Qorvo's overall financial health at a glance.

Searching For A Fresh Perspective?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

  • Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 31 best rare earth metal stocks of the very few that mine this essential strategic resource.
  • Uncover the next big thing with 25 elite penny stocks that balance risk and reward.
  • AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.